跳至主要内容
临床试验/IRCT20200204046369N1
IRCT20200204046369N1已完成2 期

Evaluation of Methylprednisolone Administration as a Therapeutic Option in the Coronavirus disease 2019 (COVID-19): A Randomized Controlled Study

Shiraz University of Medical Sciences0 个研究点目标入组 82 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • RT-PCR documented SARS-CoV-2 carriage in a nasopharyngeal and oropharyngeal sample at admission
  • Age over 18 years old
  • O2 saturation of less than 92 in room air
  • Hospitalized patients

排除标准

  • A known contraindication to treatment with the steroid
  • Breastfeeding and pregnant patients
  • Uncontrolled diabetes mellitus
  • Uncontrolled hypertension
  • patients who had previously been treated with steroids for any reason
  • O2 Saturation of above 92 in room air
  • Dissatisfaction with the study enrollment
  • Immunodeficiency disorders

研究者

相似试验